First Page | Meta Content | |
---|---|---|
Document Date: 2014-04-14 15:46:08Open Document File Size: 1,62 MBShare Result on FacebookCityBuffalo / Natick / M. Mechanism / Holzkirchen / Cary / Basel / /CompanyNovartis Pharma AG / EPO / RCA / Creative Commons / J. Pharm / Pharsight Corporation / /CountryGermany / Switzerland / United States / /Currencypence / / /EventFDA Phase / Product Release / /FacilityEPO-EPOR complex / /IndustryTermmethoxypolyethylene glycol polymer chain / advance online publication / /MedicalConditionTB / chronic renal failure / chronic kidney disease / end-stage renal disease / dissociation / koffB first-order dissociation / tumor / cancer / dissociation constant / anemia / /OrganizationFood and Drug Administration / rHuEPO administration / School of Pharmacy and Pharmaceutical Sciences / ESA administration / Department of Pharmaceutical Sciences / SC CPT / /PersonSigrid Balser / Besarab / Alexander Berghout / Phil Lowe / Van Der Graaf / Prentice / Martin Fink / Van Schaick / Giles / Jusko / /PositionGeneral / Author / pharmacokinetic model for drugs exhibiting targetmediated drug disposition / W. General / /ProductNokia E62 Smartphone / Aranesp / C50 / adenosine / T1 / ESA / ESAs / /ProgrammingLanguageMATLAB / RC / /ProvinceOrStateNew York / /TechnologyESA / Cloning / pdf / pharmacokinetics / Biopharmaceuticals / pharmacodynamics / simulation / cell assays / /URLhttp /SocialTag |